A Study of DeTIL-0255 in Adults With Advanced Malignancies

Clinical trial NCT05107739 · TERMINATED

Trial details

NCT number: NCT05107739
Sponsor: Nurix Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Endometrial Cancer Cervical Cancer

Start date: 2021-12-22
Primary completion: 2023-05-09
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.